NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences will grant up to $3 million this year to fund one pharmacogenomics knowledge resource that will "serve the needs of the entire research community" through a National Institutes of Health funding opportunity.

Direct costs for the program are limited to $2 million per year for the Pharmacogenomics Knowledge Base (PharmGKB) over a period of up to five years. This program will enable new and renewal applications for an earlier program called the Pharmacogenetics and Pharmacogenomics Knowledge Base.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.